| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.600 | None | 0.960 | 3 | 0 | 1989 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.600 | None | 0.914 | 2 | 0 | 1994 | 2019 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.600 | None | 0.889 | 2 | 0 | 1996 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.600 | None | 0.969 | 2 | 0 | 2000 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 2010 | 2020 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.600 | None | 0.958 | 1 | 0 | 1996 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.600 | None | 0.990 | 1 | 0 | 1996 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.600 | None | 0.941 | 1 | 0 | 2000 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.600 | None | 0.962 | 1 | 0 | 2003 | 2019 | ||||||||
|
transforming growth factor beta induced | 0.484 | 0.769 | 6.0E-08 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 2003 | 2012 | ||||||||
|
mitofusin 2 | 0.471 | 0.846 | 0.99 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2015 | 2016 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.957 | 3 | 0 | 1997 | 2020 | ||||||||
|
NADPH oxidase 4 | 0.471 | 0.885 | 5.8E-20 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2020 | ||||||||
|
cellular communication network factor 2 | 0.399 | 0.846 | 5.0E-04 |
|
disease | 0.300 | None | 0.974 | 2 | 0 | 1998 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2008 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.960 | 2 | 0 | 2003 | 2019 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.300 | None | 0.990 | 1 | 0 | 1995 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.300 | None | 0.923 | 1 | 0 | 2006 | 2019 | ||||||||
|
hepatitis A virus cellular receptor 1 | 0.489 | 0.885 | 8.5E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2019 |